Skip to main content

Ruben J. Boado, PhD

Vice-President at ArmaGen Technologies, Inc.

Adjunct Professor of Medicine and member of the Brain Research Institute at University of California at Los Angeles

Location: Santa Monica, CA United States

Ruben Boado received a PhD in biochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires (UBA), Argentina, in 1982. He completed a postdoctoral fellowship and conducted research as established investigator at the UBA Center for Nuclear Medicine. In 1985, Dr. Boado joined the UCLA School of Medicine with a grant from the Fogarty International Center, National Institutes of Health (NIH). He was appointed Visiting Research Endocrinologist in the UCLA Department of Medicine in 1988, Assistant Professor in 1991, Associate Professor in 1997, and Professor of Medicine in 2001.

At ArmaGen, Dr. Boado leads the molecular biology division, which is responsible for the genetic engineering, expression, and validation of novel recombinant fusion proteins, which cross the human blood-brain barrier (BBB). At UCLA, Dr. Boado's research program examined BBB genomics, and the genetic engineering of plasmid DNA for non-viral gene therapy for the brain.

He is a member of The Society for Neuroscience, and has authored more than 150 scientific journal articles and book chapters in his field. He has served on numerous scientific review committees including the US Department of Energy, the Alzheimer’s Association and the NIH. Dr. Boado is co-inventor of U.S. and European patents related to BBB drug delivery.

Associated Grants

  • GDNF Fusion Protein for Blood-Brain Barrier Delivery and Treatment in Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.